C3 Jian, Inc. announced the appointment of Richard Bastiani, Ph.D., as a member of its Board of Directors. Dr. Bastiani, who has over 40 years of industry experience, is currently a member of the Board of Directors of Abaxis, DiscoveRx, and Pathwork Diagnostics. Formerly, Dr. Bastiani served as Chairman of the Board of Directors of ID Biomedical Corporation until its acquisition by GlaxoSmithKline.

Dr. Bastiani started his career at Palo Alto, where he held various positions over a 25-year career, ultimately becoming its President in 1991. Dr. Bastiani led Syva until its multi-billion dollar acquisition by Hoechst AG of Germany in 1995. After retiring from Syva, Dr. Bastiani served as President of Dendreon.